EUVIMEDEUVIMED entdecken
Validierungsstudie

Leveraging Implantable Cardiac Defibrillator Remote Transmissions to Predict the Occurrence of Atrial Fibrillation

Michael Scheid, Kristie M Coleman iD, Steven Mullane, Dimitrios Varrias, Emmanouil Mountantonakis, Gregg Husk, Kabir Bhasin, Nicholas Skipitaris, Laurence M Epstein, Theodoros P Zanos, Stavros E Mountantonakis

Journal of Cardiovascular Electrophysiology · 2025

DOI: 10.1111/jce.70072 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Michael Scheid und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Defibrillators, Implantable, Machine Learning, Remote Sensing Technology. Die Arbeit nennt 22 Literaturangaben. Gefördert von: This study was supported by Biotronik., Biotronik.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) and heart failure (HF) frequently coexist in patients, with the development of AF often preceding HF decompensation. We sought to evaluate whether daily remote monitoring of ICD parameters could predict AF occurrence using machine learning techniques in a real‐world cohort.

Methods

Data from patients with primary prevention ICDs transmitted daily to the Northwell centralized remote monitoring center between 2012 and 2021 were extracted. Using this data, an XGBoost model was trained to predict AF occurrence with a 3‐day time horizon using a 14‐day data collection sequence. Model predictive performance was validated retrospectively and prospectively, using mean ROC AUC and PR AUC across all folds. Feature importance was assessed using Shapley additive explanation (SHAP) values.

Results

A total of 207 patients, 69.0% male, median age of 65.0 [57, 72] years, median ejection fraction of 30% [25, 40], 13.0% paroxysmal AF, and 35.7% with ischemic cardiomyopathy were monitored for over 36 months. Our model predicted AF occurrence within the following 3 days in 49 (23.7%) patients after a median of 36 months post‐implant with an area under the receiver operating characteristic curve (AUROC) of 0.79 and an area under the precision‐recall curve of 0.10 (AUPRC). The model has a specificity of 99% in the validation data set. Key variables included RV and RA sensing amplitudes as well as the pulse width. Validation was performed using K‐fold cross‐validation methods without a significant drop in performance metrics.

Conclusion

This exploratory analysis suggests a machine learning approach has the potential to predict AF from daily remote monitoring of ICD parameters. This risk prediction algorithm requires external validation in a large‐scale multi‐center clinical trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationDefibrillators, ImplantableMachine LearningRemote Sensing TechnologyElectric CountershockHeart RatePrimary PreventionDecision Support TechniquesHeart FailureHumansMaleFemaleAgedMiddle AgedPredictive Value of TestsRetrospective StudiesTime FactorsRisk FactorsRisk AssessmentReproducibility of ResultsProspective StudiesAction PotentialsTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationcardiac implantable electronic devicemachine learningremote monitoring

Autor:innen und Institutionen

  • Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
  • Northwell Cardiovascular Institute, Center for Arrhythmias, New Hyde Park, New York, USA.
  • BIOTRONIK Inc., Lake Oswego, Oregon, USA.
  • Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.

ORCID-Profile: Kristie M Coleman

Förderung

  • This study was supported by Biotronik.
  • Biotronik

Zitieren

APA

Scheid, M., Coleman, K. M., Mullane, S., Varrias, D., Mountantonakis, E., Husk, G., Bhasin, K., Skipitaris, N., Epstein, L. M., Zanos, T. P., & Mountantonakis, S. E. (2025). Leveraging Implantable Cardiac Defibrillator Remote Transmissions to Predict the Occurrence of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70072

Vancouver

Scheid M, Coleman KM, Mullane S, Varrias D, Mountantonakis E, Husk G, et al. Leveraging Implantable Cardiac Defibrillator Remote Transmissions to Predict the Occurrence of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.70072

BibTeX
@article{Scheid2025,
  author = {Scheid, Michael and Coleman, Kristie M and Mullane, Steven and Varrias, Dimitrios and Mountantonakis, Emmanouil and Husk, Gregg and Bhasin, Kabir and Skipitaris, Nicholas and Epstein, Laurence M and Zanos, Theodoros P and Mountantonakis, Stavros E},
  title = {Leveraging Implantable Cardiac Defibrillator Remote Transmissions to Predict the Occurrence of Atrial Fibrillation},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  doi = {10.1111/jce.70072}
}
Kostenlos starten →